{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:09:51Z","timestamp":1750158591856},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>We report the case of a 10-year-old child treated for latent tuberculosis infection (LTBI) with pyrazinamide (PZA) and levofloxacin after contact with a smear-positive multidrug-resistant tuberculosis adult. Over the course of the treatment, the patient developed a drug-induced fulminant hepatitis attributed to the combination of PZA and levofloxacin. This case highlights the hepatotoxicity of the association of second-line anti-TB treatment in children.<\/jats:p>","DOI":"10.1097\/inf.0000000000002413","type":"journal-article","created":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T21:32:12Z","timestamp":1563744732000},"page":"1025-1026","source":"Crossref","is-referenced-by-count":4,"title":["Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin"],"prefix":"10.1097","volume":"38","author":[{"given":"Annabelle","family":"Huguet","sequence":"first","affiliation":[{"name":"Service d\u2019Urgences et de R\u00e9animation P\u00e9diatrique, H\u00f4pital Femme-M\u00e8re-Enfant, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[{"name":"Service des maladies infectieuses, H\u00f4pital de la Croix Rousse, Groupement Hospitaliser Nord, Hospices Civils de Lyon, Universit\u00e9 Claude Bernard Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Ohlmann","sequence":"additional","affiliation":[{"name":"Service de Pneumologie p\u00e9diatrique, H\u00f4pital Femme-M\u00e8re-Enfant, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Collardeau-Frachon","sequence":"additional","affiliation":[{"name":"Service de Pathologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Universit\u00e9 Claude Bernard Lyon 1, Bron, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Gillet","sequence":"additional","affiliation":[{"name":"Service d\u2019Urgences et de R\u00e9animation P\u00e9diatrique, H\u00f4pital Femme-M\u00e8re-Enfant, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","article-title":"Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.","volume":"383","author":"Jenkins","year":"2014","journal-title":"Lancet"},{"key":"R3-20240429","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0041-3879(77)90022-8","article-title":"The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.","volume":"59","author":"Girling","year":"1978","journal-title":"Tubercle"},{"key":"R4-20240429","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/rccm.200802-355OC","article-title":"Hepatotoxicity of pyrazinamide: cohort and case-control analyses.","volume":"177","author":"Chang","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF00716476","article-title":"Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.","volume":"146","author":"van Aalderen","year":"1987","journal-title":"Eur J Pediatr"},{"key":"R6-20240429","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199404283301718","article-title":"Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis.","volume":"330","author":"Horn","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-20240429","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.","volume":"167","author":"Papastavros","year":"2002","journal-title":"CMAJ"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.","volume":"33","author":"Adler-Shohet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20240429","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1473-3099(11)70366-8","article-title":"Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.","volume":"12","author":"Seddon","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T18:07:28Z","timestamp":1714414048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002413","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}